다운스트림 정제는 바이오의약품 생산 비용의 60% 이상을 차지하며, 이는 약물 접근성과 수익성에 주요 병목 현상으로 작용합니다. 높은 크로마토그래피 비용과 공급망 리스크에 힘입어 업계는 공정 혁신, CDMO 아웃소싱, 공급망 다양화 등을 통해 기술 주도적 비용 절감을 추구하고 있습니다. 본 문서는 효율적이고 안정적인 제조를 위한 비용 구조 및 솔루션을 검토합니다.

MORE DETAILS

Three cutting-edge trends in downstream processing: continuous, intelligent, and green.

2026-02-13

This paper reviews three key trends: continuous manufacturing, AI & digital twins, and green materials & circular economy. Their integration is building smarter, more efficient biopharmaceutical factories, delivering more accessible and reliable medicines to patients.

MORE DETAILS

The global bioreactor market is entering a new technology-driven era: Insights and strategic outlook for 2025-2029.

2026-03-16

Inside precise stainless steel tanks, cell culture media circulates under intelligent control as real-time data flickers on screens—a microcosm of a multi-billion dollar market. In 2024, the global bioreactor market reached 7,079.1 million and is projected to surpass the 10,083.2 million mark by 2029.

MORE DETAILS

Upstream equipment and consumables market for bioreactors: technological innovation, competitive landscape and supply chain strategy

2026-04-11

The upstream bioreactor market, covering equipment and key consumables, is the physical foundation of bioprocessing. This article focuses on the technical evolution, market competition, and supply chain of equipment (control systems, sensors) and core consumables (single-use components, media). Through analysis of product categories, technical parameters, supplier strategies, and cost structures, it reveals the inner logic and future direction of this market segment.

MORE DETAILS

In-depth analysis of the current status and future trends of the global bioreactor market

2026-01-05

This article provides a systematic analysis of the global bioreactor market, covering size, key drivers, technical segments, regional dynamics, and future trends. As critical equipment in biopharmaceuticals, tissue engineering, and food industries, bioreactor demand is intrinsically linked to biotech sector growth. Based on authoritative data, we deconstruct upstream manufacturing and downstream application markets to provide strategic insights for industry stakeholders.

MORE DETAILS

Deep Mastery of Cell Culture Technology: From Mode Selection to Intelligent Control

2026-05-19

This article explores the core of biopharmaceutical upstream processing: cell culture. It systematically describes mammalian cell culture modes (batch, fed-batch, perfusion), details the seed expansion strategy from cell banks to production bioreactors, and highlights how PAT and QbD frameworks enable lean control over cell growth and protein expression. It provides a comprehensive technical perspective on modern cell culture process development and execution.

MORE DETAILS

Building Cell Factories: The Synergistic Evolution of Culture Medium Design and Bioreactor Engineering

2026-01-01

This article focuses on the two pillars of upstream bioprocessing: culture media and bioreactors. It analyzes the logic of chemically defined media development and component optimization while comparing bioreactor types (stirred-tank vs. single-use) regarding design, operation, and scale-up. By explaining how these systems maintain the optimal environment for cell growth, it reveals the path to achieving robustness and economic efficiency in upstream processes.

MORE DETAILS

Uma nova era nos estágios iniciais da fabricação biofarmacêutica: semelhanças entre tecnologias avançadas de inovação contínua, inteligente e modular

2026-01-11

Este artigo examina as tendências e estratégias de ponta no bioprocessamento em estágio inicial. Discute a mudança da produção em batelada para a produção contínua, bem como a forma como a inteligência artificial, a aprendizagem automática e a automação contribuem para o desenvolvimento de processos inteligentes. Também aborda as novas demandas das terapias celulares e genéticas e as perspetivas para a biomanufatura verde, delineando a próxima mudança de paradigma no bioprocessamento upstream.

MORE DETAILS

Devoxin is a globally leading provider of bioprocess technology and solutions.

Navigation: About Devoxin; Product Overview; Solution; Technology Platform

Newsletter: Subscribe to access product market trends, priority quotation services and trade cooperation updates.

Contact Us: No. 58, Lane 766, Fuyong Road, Songjiang District, Shanghai, China; DWXBIO@163.com; +86 021-67619937 +86 18052305973 +86 13611913074

We use Cookie to improve your online experience. By continuing browsing this website, we assume you agree our use of Cookie.

Regulations

technology

Upstream processes

market

Downstream processes

News

비용 절감 캠페인: 다운스트림 정제 비용이 60%를 차지, 혁신 기술은 어떻게 돌파할 것인가?

Three cutting-edge trends in downstream processing: continuous, intelligent, and green.

The global bioreactor market is entering a new technology-driven era: Insights and strategic outlook for 2025-2029.

Upstream equipment and consumables market for bioreactors: technological innovation, competitive landscape and supply chain strategy

In-depth analysis of the current status and future trends of the global bioreactor market

Deep Mastery of Cell Culture Technology: From Mode Selection to Intelligent Control

Building Cell Factories: The Synergistic Evolution of Culture Medium Design and Bioreactor Engineering

Uma nova era nos estágios iniciais da fabricação biofarmacêutica: semelhanças entre tecnologias avançadas de inovação contínua, inteligente e modular